about
Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot"Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studiesEpigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancerPredictive value of symptoms for early detection of ovarian cancerPolymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white womenNetwork-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer RiskGenome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer TypesPALB2, CHEK2 and ATM rare variants and cancer risk: data from COGSA genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.Common variants at 19p13 are associated with susceptibility to ovarian cancer.Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.History of hypertension, heart disease, and diabetes and ovarian cancer patient survival: evidence from the ovarian cancer association consortium.Cigarette smoking is associated with adverse survival among women with ovarian cancer: Results from a pooled analysis of 19 studies.Integration of Population-Level Genotype Data with Functional Annotation Reveals Over-Representation of Long Noncoding RNAs at Ovarian Cancer Susceptibility Loci.No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival.A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancerRecreational physical inactivity and mortality in women with invasive epithelial ovarian cancer: evidence from the Ovarian Cancer Association ConsortiumChronic Recreational Physical Inactivity and Epithelial Ovarian Cancer Risk: Evidence from the Ovarian Cancer Association ConsortiumAssessing the genetic architecture of epithelial ovarian cancer histological subtypes.Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk.Assessment of Multifactor Gene-Environment Interactions and Ovarian Cancer Risk: Candidate Genes, Obesity, and Hormone-Related Risk Factors.Investigation of Exomic Variants Associated with Overall Survival in Ovarian Cancer.No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.Use of nonsteroidal antiinflammatory drugs and risk of endometrial cancerRecreational physical activity and risk of epithelial ovarian cancerA genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2.Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA.ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium study.Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancerPolymorphism in the GALNT1 gene and epithelial ovarian cancer in non-Hispanic white women: the Ovarian Cancer Association Consortium.Polymorphisms in nucleotide excision repair genes and endometrial cancer risk.Risk of epithelial ovarian cancer in relation to use of antidepressants, benzodiazepines, and other centrally acting medications.Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer.Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies.Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk.Genetic variation in TYMS in the one-carbon transfer pathway is associated with ovarian carcinoma types in the Ovarian Cancer Association ConsortiumRecent alcohol consumption and risk of incident ovarian carcinoma: a pooled analysis of 5,342 cases and 10,358 controls from the Ovarian Cancer Association Consortium.Genetic variation in insulin-like growth factor 2 may play a role in ovarian cancer riskHormonal factors and risks of esophageal squamous cell carcinoma and adenocarcinoma in postmenopausal womenThe role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing
P50
Q21144976-1D457036-C5E1-4B4C-B384-4F625BB00208Q24619808-A465E349-E4ED-4DC0-B8C6-32717A738958Q24633316-E9673F28-2F0D-4AF4-9D5E-7F46D832060DQ24644590-5D085BAE-5892-4220-AC44-C79ECBAB0EA1Q24648412-090FB84B-39D5-4036-ACFB-6FC04E83980AQ26799669-95C9F82C-2D71-47A5-AB06-547B9B530E47Q28388497-F6D324FF-1D4B-4F9D-BC3B-F36918B5C4CDQ28584533-E4B2B1FC-6DA7-4897-B566-831143A5694CQ29417084-3822B2DD-B221-4FDF-BBCB-20C51BC313E8Q29417145-73A8D6E0-FE55-4DAA-82FD-3F0371F10F88Q30252854-A463A062-D2B2-46A8-BD4C-836A2C6C506CQ30252952-8DBBB034-BDFC-4D16-8164-C18A156A5054Q30275068-545A4556-1512-43A4-8B04-703E96ACC2D4Q30275132-60FE8EC3-9562-471A-880A-73AE133590ACQ30275832-19A01BC8-9B94-4D63-B8C0-FF6EF884D078Q30276359-038A86B1-8122-4EAA-81D9-D3CF3A97D76CQ30276610-651AE6C3-10D3-4663-A42C-675C24C1C2C1Q30276777-CCA4F065-806A-4912-B27E-92295D11A303Q30276986-F81BCD16-06EC-4954-A3CC-2362DC1ACBB5Q30277016-84CCFB2C-682C-4A70-AB20-AAC9D9206ABBQ30277151-11A6038E-8BE1-4126-8C60-D1285E680A53Q30277784-6E5E225E-6328-4556-9B91-0EFADA4C9536Q30374367-140170DB-05AF-4E74-B44E-6636ADFB63E8Q33566700-9080BD80-32AD-4167-996C-F594A87F4A7FQ33732557-24E74276-24C6-419A-9EC4-F2680A28F38FQ33747778-AEFF23FB-6410-4D67-B3A9-FBF93FF2BE4CQ33778612-FB371EA5-391D-457D-BE06-64CD1E377864Q33824208-849093FE-C11A-4D17-B4A8-229C84098295Q33847791-471C8BB6-D64E-48DD-BE6D-C399916CB26EQ33891803-51120B6D-CC5A-4C9D-9C72-DFD9BD194797Q33958989-07F3572F-BB4F-4B14-A55F-7FCF458AC161Q34119029-F8B54133-AEAA-40D8-986C-9068EC80C76AQ34126314-F5C2B5ED-BE8E-4704-98FA-EC86974E15AAQ34338047-8977107D-40D1-4A51-90C1-A9CCB4936A4FQ34342248-A9F85283-FCAB-4F7D-BA84-970A5B834D02Q34453723-8E93F140-5B55-4DE5-8093-EC773789D240Q34557167-B1934C0B-0021-4A44-9D05-76B31E8D63A6Q34955369-60B30036-401F-45CD-B4BE-CFC121942330Q35023980-23D2D119-025F-47A8-80DF-FCD76E4AD2F7Q35024008-8E205ED4-B65D-40A2-A888-930395C84245
P50
name
Mary Anne Rossing
@en
Mary Anne Rossing
@nl
type
label
Mary Anne Rossing
@en
Mary Anne Rossing
@nl
prefLabel
Mary Anne Rossing
@en
Mary Anne Rossing
@nl